AVTOZMA (tocilizumab)

**Product type:** Human Prescription Drug

**Active ingredient:** TOCILIZUMAB

**Strength:** 162 mg/.9mL

**Dosage form:** Injection, Solution

**Route:** Intravenous

**Labeler:** CELLTRION USA, Inc.

**Marketing category:** BLA (BLA761420)

**Pharmacologic class:** Interleukin 6 Receptor Antagonists [MoA], Interleukin-6 Receptor Antagonist [EPC]